Supernus Pharmaceuticals
SUPN
SUPN
289 hedge funds and large institutions have $1.81B invested in Supernus Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 119 increasing their positions, 78 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.13% more ownership
Funds ownership: 99.31% → 101.44% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
45% less call options, than puts
Call options by funds: $8.25M | Put options by funds: $15.1M
Holders
289
Holding in Top 10
1
Calls
$8.25M
Puts
$15.1M
Top Buyers
| 1 | +$15.9M | |
| 2 | +$12.2M | |
| 3 | +$11.4M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.66M |
| 5 |
Two Sigma Advisers
New York
|
+$8.14M |
Top Sellers
| 1 | -$47.1M | |
| 2 | -$8.43M | |
| 3 | -$5.82M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.61M |
| 5 |
Morgan Stanley
New York
|
-$5.26M |